NCT02741726

Brief Summary

The purpose of this study is to compare the effects of dual acupoints and single acupoint transcutaneous electrical acupoint stimulation (TEAS) pretreatment on incidence of Post-Mastectomy Pain Syndrome(PMPS) in patients undergoing operation of breast cancer.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
593

participants targeted

Target at P75+ for not_applicable pain

Timeline
Completed

Started May 2016

Longer than P75 for not_applicable pain

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 13, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 18, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

May 25, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 23, 2017

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 23, 2018

Completed
Last Updated

October 16, 2019

Status Verified

October 1, 2019

Enrollment Period

1.4 years

First QC Date

April 13, 2016

Last Update Submit

October 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of chronic pain six months after surgery

    six months after surgery

Secondary Outcomes (11)

  • Incidence of chronic pain three months after surgery

    three months after surgery

  • Remifentanil consumption during the surgery

    from start of surgery to end of surgery, at an average of 2.5 hours

  • the time to the first verbal response

    end of the anesthetics infusion to patient's first response to verbal command,on an average of 30 minutes

  • the time to extubation

    end of the anesthetics infusion to extubation,on an average of 30 minutes

  • postoperative nausea and vomiting within 24 h after surgery

    end of surgery to 24 hours after surgery,on an average of 24 hours

  • +6 more secondary outcomes

Study Arms (3)

dual acupoint stimulation

EXPERIMENTAL

The acupoints of dual point group are bilateral Neiguan points(PC6) combined with Danzhong point(RN17), electric stimulation was given through electrode attached to the acupoints.

Device: acupoint stimulation

single acupoint stimulation

EXPERIMENTAL

The acupoints of single point group is bilateral Neiguan points(PC6), Electric stimulation was given through electrode attached to the acupoints.

Device: acupoint stimulation

no stimulation

PLACEBO COMPARATOR

false stimulation group only attach electrodes without electric current.

Device: no stimulation

Interventions

Electric stimulation was given through electrode attached to acupoints

Also known as: transcutaneous electrical acupoint stimulation
dual acupoint stimulationsingle acupoint stimulation

patients were only attached electrodes without electric current

no stimulation

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Scheduled for operation of breast cancer;
  • ASA(American Society of Anesthesiologists)I-II;
  • Aged between 18 and 65;
  • Informed consented。

You may not qualify if:

  • Suffered from the contraindication of TEAS including the local skin breakage, infection or planted with the electrophysiology device;
  • Unable to communicate and coordinate with the researcher, such as suffering from language comprehension deficits or mental diseases;
  • Certain/suspicious addiction with alcohol, analgesics or other drugs;
  • Unstable Angina or myocardial infarction occurred in 3 months; NYHA(New York Heart Association) is 3 or higher;
  • Blood pressure ≥ 180/110 mm Hg while preoperative visiting;
  • Suffered from diabetic complications including diabetic ketoacidosis, hyperosmolar coma, infection, macroangiopathy, diabetic nephropathy, retinopathy, cardiomyopathy, neuropathy and diabetic foot;
  • Severe dysfunction of liver or kidney meaning one of ALT(Alanine Transaminase), AST(Aspartate Transaminase), ALP(alkaline phosphatase) or TBIL(total bilirubin) is 2 times higher that normal or creatinine clearance \< 30 ml/min or serum creatinine \> 177umol/L;
  • Participate in the other clinical trial 3 month before the enrollment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

First Afiliated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Location

People's hospital of Zhengzhou University

Zhengzhou, Henan, 450003, China

Location

First Afiliated Hospital of Zhengzhou University

Zhengzhou, Henan, 450052, China

Location

Tangdu Hospital, Fourth Military Medical University

Xi'an, Shaanxi, 710005, China

Location

First Afiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, 710022, China

Location

Xijing Hospital, Fourth Military Medical University

Xi'an, Shaanxi, 710032, China

Location

Related Publications (1)

  • Lu Z, Wang Q, Sun X, Zhang W, Min S, Zhang J, Zhao W, Jiang J, Wang Y, Zhu Y, Zheng L, Wang Y, Guo Y, Zhang L, Wang L, Lei C, Liu T, Yang X, Zhang J, Li C, Zhang N, Dong H, Xiong L. Transcutaneous electrical acupoint stimulation before surgery reduces chronic pain after mastectomy: A randomized clinical trial. J Clin Anesth. 2021 Nov;74:110453. doi: 10.1016/j.jclinane.2021.110453. Epub 2021 Jul 13.

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Hailong Dong

    Air Force Military Medical University, China

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

April 13, 2016

First Posted

April 18, 2016

Study Start

May 25, 2016

Primary Completion

October 23, 2017

Study Completion

October 23, 2018

Last Updated

October 16, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will share

IPD including those about primary endpoint and secondary endpoints would be available to other researchers.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
the data will become available after manuscript published, for 5 years.

Locations